Related Experiment Videos
CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand
Talin Haritunians1, Jim Boulter, Carol Hicks
1Department of Human Genetics, University of California, Los Angeles 90095, USA.
Circulation Research
|March 23, 2002
Summary
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a vascular dementia. CADASIL mutations in Notch3 do not impair cell-surface expression or ligand binding, suggesting normal receptor function.
Area of Science:
- Neuroscience
- Genetics
- Vascular Biology
Background:
- Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a genetic vascular dementia.
- It stems from mutations in the Notch3 gene, affecting arteriolar smooth muscle cells.
- The functional impact of these Notch3 mutations on receptor activity remains unclear.
Purpose of the Study:
- To investigate the functional consequences of CADASIL-associated Notch3 mutations.
- To determine if altered cysteine residues affect Notch3 receptor expression and ligand binding.
Main Methods:
- Engineered four CADASIL-like mutations into rat Notch3.
- Assessed cell-surface expression of mutant Notch3 receptors.
- Evaluated the ligand-binding capabilities of mutant Notch3 receptors.
Main Results:
- Engineered CADASIL-like mutations did not impede Notch3 receptor cell-surface expression.
- The presence of unpaired cysteine residues did not impair Notch3 ligand binding.
- These findings suggest that CADASIL mutations may not alter fundamental Notch3 receptor function.
Conclusions:
- CADASIL-associated Notch3 mutations do not disrupt essential receptor functions like cell-surface expression and ligand binding.
- The underlying mechanisms of CADASIL may involve functions beyond these basic receptor properties.
- Further research is needed to elucidate the precise pathogenic pathways of CADASIL.